Location History:
- Minoo, JP (2002 - 2008)
- Osaka, JP (2012)
Company Filing History:
3 out of 1,179 
1 out of 1,858 
1 out of 246 
Years Active: 2002-2012
Title: **Masayuki Ii: Innovator in Pharmaceutical Sciences**
Introduction
Masayuki Ii, hailing from Minoo, Japan, is a prominent inventor in the field of pharmaceutical sciences. His innovative contributions are reflected in his four patents, which focus primarily on drug discovery and development aimed at treating a variety of serious diseases.
Latest Patents
Among Masayuki Ii's latest patents is a groundbreaking **Screening Method for a Substance that Binds to an Intracellular Region of TLR4**. This invention provides a novel method for screening drugs intended for the prophylaxis or treatment of various diseases, including cardiac disease, autoimmune disease, and infectious diseases. The method focuses on identifying substances that bind to TLR4, inhibiting signal transduction to produce therapeutic effects. Additionally, he has patented a method concerning **Substituted Aromatic-Ring Compounds**, which outlines cyclohexene derivatives with sulfamoyl and ester groups. These compounds show promise in decreasing nitric oxide and cytokine production, suggesting potential uses for a range of diseases, including sepsis and septic shock.
Career Highlights
Throughout his career, Masayuki Ii has worked with esteemed organizations such as Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience at these companies has greatly influenced his innovative approaches to drug development and production processes.
Collaborations
Masayuki Ii has collaborated with notable colleagues in his field, including Norikazu Tamura and Takashi Ichikawa. These partnerships have likely contributed to the refinement of his inventions and the expansion of research in pharmaceutical innovations.
Conclusion
Masayuki Ii's contributions to pharmaceutical sciences underscore his role as a significant inventor. With a strong background in drug discovery and a focus on addressing critical health challenges, his patents not only embody innovative ideas but also hold the potential to enhance therapeutic strategies in the medical field.